Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health to Deliver Oral Comments at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs
Testimony of Brian Blase before the United States House Judiciary Committee Subcommittee on the Administrative State, Regulatory Reform, and Antitrust — "Examining Healthcare Markets: Fraud and Competition"